• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Ting,CUI Xiaokang,LI Min,FENG Rui,REN Jieru,XU Xinping,WU Jiyong.Analysis of tigecycline-induced serious adverse drug reactions in Shandong Province in past 10 years[J].Journal Of Pharmaceutical Research,2024,43(10):1035-1040[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2468times   Download 2412次 QR Code for this article
Scan with your phone!
山东省近10年替加环素致严重不良反应分析
王婷1,崔小康2,李敏3,冯蕊1,任洁如1,徐馨平1,吴记勇1
Font:Larger+|Default|Smaller-
(1.山东省第二人民医院药学部,山东 济南 250022;2.山东省药品不良反应监测中心,山东 济南 250014;3.济南市药品不良反应监测中心,山东 济南 250013)
摘要:
目的 分析替加环素引起严重不良反应的发生情况、临床表现与预后等特征,为优化治疗方案、降低不良反应发生率提供借鉴和参考。方法 对2013年1月1日至2023年2月28日99例山东省替加环素导致的严重不良反应报告进行回顾性分析。结果 99例严重不良反应中,男75例,女24例,患者平均年龄(64 ± 18)岁。血液系统不良反应居首位,发生时间在用药后60 min ~25 d不等。不良反应结果:13例痊愈,74例好转,3例未好转,9例不详。对原患疾病的影响中有47例不明显,44例导致病程延长,8例病情加重。结论 建议对中老年患者及易发生严重不良反应的高危患者做好药学监护,一旦发生严重不良反应做相应的对症处理和支持疗法,保证用药安全。
关键词:  替加环素  严重不良反应  山东省
DOI:10.13506/j.cnki.jpr.2024.10.019
基金项目:山东省药品化妆品监测哨点课题(No.2022SDADRKY10);山东省第二人民医院项目(No.2022SDADRKY10)
Publication Date:October 30, 2024
Analysis of tigecycline-induced serious adverse drug reactions in Shandong Province in past 10 years
WANG Ting1,CUI Xiaokang2,LI Min3,FENG Rui1,REN Jieru1,XU Xinping1,WU Jiyong1
(1.Department of Pharmacy, Shandong Second Provincial General Hospital, Jinan 250022, China;2.Shandong Provincial Center for Adverse Drug Reaction Monitoring, Jinan 250014, China;3.Jinan Adverse Drug Reaction and Medical Device Adverse Event Monitoring Center, Jinan 250013, China)
Abstract:
Objective To analyze the characteristics of severe adverse reactions caused by tigecycline, and to provide reference for optimizing the treatment plan and reducing the incidence of adverse reactions.Methods A retrospective analysis was performed on 99 cases of severe adverse reactions caused by tigecycline in Shandong Province from January 1,2013 to February 28,2023.Results 99 cases of serious adverse reactions, 75 cases of male, female 24 cases ;The mean age of the patients was ( 64±18 ) years. Hematological system damage ranked first, and the occurrence time ranged from 60 min to 25 d after administration. The results of adverse reactions showed that 13 cases were cured, 74 cases were improved, 3 cases were not improved, and 9 cases were unknown. The effect on the original disease was not obvious in 47 cases, resulting in 44 cases of prolonged course of disease and 8 cases of exacerbation. Conclusion It is suggested that pharmaceutical care should be carried out for middle-aged and elderly patients and high-risk patients prone to serious adverse reactions. Once serious adverse reactions occur, corresponding symptomatic treatment and supportive therapy should be carried out to ensure the safety of medication.
Key words:  Tigecycline  Serious adverse reactions  Shandong Province
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.